MNMD Stock Price | Mind Medicine Inc P/E, Revenue, EPS, & Forecasts

Mind Medicine Inc • MNMD

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Mind Medicine Inc

Ticker

MNMD

Trading on

NASDAQ

ISIN

CA60255C8850

Industry

Biotechnology

Sector

Healthcare

CEO

Robert Barrow

Headquarters

One World Trade Center, New York, NY, United States, 10007

Employees

Website

mindmed.co

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.

Metrics

BasicAdvanced

Market cap

$1.21B

P/E ratio

EPS

-$1.98

Dividend Yield

0.00%

Beta

2.8

Forward P/E ratio

EBIDTA

$-152M

Ex dividend date

Price & volume

Market cap

$1.21B

Average daily volume

1.5M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

9.01

Earnings

EPS

-$1.98

EPS estimate (current quarter)

-$0.50

EPS estimate (next quarter)

-$0.51

EBITDA

$-152M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

2.8

52-week High

$14.43

52-week Low

$4.70

50-day moving average

$12.06

200-day moving average

$8.74

Short ratio

5.46

Short %

12.55%

Management effectiveness

ROE (TTM)

-85.59%

ROA (TTM)

-33.95%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

97.2M

Float

97.6M

Insiders %

0.61%

Institutions %

41.26%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 11 analysts.

Average price target

$25.64

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.41

-$0.28

-47.16%

Q4 • 24Missed

-$0.35

-$0.53

33.96%

Q1 • 25Beat

-$0.50

-$0.37

-35.14%

Q2 • 25Missed

-$0.78

-$0.50

-56.00%

Q3 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-42.7M

-∞%

Q2 • 25

$0M

$-67.3M

-∞%

Q3 • 25

NaN%

57.37%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$265M

$79.7M

30.06%

Q2 • 25

$237M

$106M

44.88%

Q3 • 25

-10.63%

33.42%

49.28%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-29.6M

$-39.5M

$19.7M

$-29.6M

Q2 • 25

$-29.6M

$15.4M

$0.7M

$-29.6M

Q3 • 25

-0.11%

-138.97%

-96.19%

-0.11%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Mind Medicine Inc share?

Mind Medicine Inc shares are currently traded for undefined per share.

How many shares does Mind Medicine Inc have?

Mind Medicine Inc currently has 97.2M shares.

Does Mind Medicine Inc pay dividends?

No, Mind Medicine Inc doesn't pay dividends.

What is Mind Medicine Inc 52 week high?

Mind Medicine Inc 52 week high is $14.43.

What is Mind Medicine Inc 52 week low?

Mind Medicine Inc 52 week low is $4.70.

What is the 200-day moving average of Mind Medicine Inc?

Mind Medicine Inc 200-day moving average is $8.74.

Who is Mind Medicine Inc CEO?

The CEO of Mind Medicine Inc is Robert Barrow.

How many employees Mind Medicine Inc has?

Mind Medicine Inc has 74 employees.

What is the market cap of Mind Medicine Inc?

The market cap of Mind Medicine Inc is $1.21B.

What is the P/E of Mind Medicine Inc?

The current P/E of Mind Medicine Inc is null.

What is the EPS of Mind Medicine Inc?

The EPS of Mind Medicine Inc is -$1.98.

What is the PEG Ratio of Mind Medicine Inc?

The PEG Ratio of Mind Medicine Inc is null.

What do analysts say about Mind Medicine Inc?

According to the analysts Mind Medicine Inc is considered a buy.